Drugs Made In America Acquisition DMIIR
NASDAQ DMIIR
$0.07 -0.01 (-7.04%)
As of: Sep 2, 2026 · 12:48 PM EDT

Drugs Made In America Acquisition (DMIIR) Total Current Liabilities (2024 - 2026)

Drugs Made In America Acquisition (DMIIR) posted quarterly Total Current Liabilities of $300864.0 for Q4 2025, up 18.09% year-over-year from $254783.0 in Q4 2024, and down 55.58% quarter-over-quarter from $677345.0 in Q3 2025.

Analysis

Drugs Made In America Acquisition (DMIIR) Total Current Liabilities (2024 - 2026) Analysis & Trends

Drugs Made In America Acquisition (DMIIR) has reported Total Current Liabilities for 2 consecutive years, with $300864.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Total Current Liabilities rose 18.09% year-over-year to $300864.0; the TTM figure through Dec 2025 stood at $300864.0 (up 18.09% YoY), while the FY2025 annual figure was $300864.0, up 18.09% from the prior year.
  • Total Current Liabilities fell to $300864.0 in Q4 2025 per DMIIR's latest filing, from $677345.0 in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $677345.0 in Q3 2025 and bottomed at $254783.0 in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Cluster Group Holdings 8.00 Bn 8.00 Bn - 76,013.00
2 Agriculture & Natural Solutions Acquisition 853.42 Mn 853.17 Mn - 22.16 Mn
3 K&F Growth Acquisition 836.15 Mn 836.15 Mn - 6,077.00
4 Armada Acquisition 666.54 Mn 666.49 Mn - 5.47 Mn
5 Pioneer Acquisition I 652.74 Mn 652.27 Mn - 298,549.00
6 Oxley Bridge Acquisition 652.11 Mn 652.11 Mn - 146,923.00
7 Titan Acquisition 651.43 Mn 941.85 Mn - 1.33 Mn
8 GSR IV Acquisition 622.22 Mn 622.22 Mn - 37,265.00
9 Launch One Acquisition 618.70 Mn 618.70 Mn - 2.13 Mn
10 Drugs Made In America Acquisition 5.10 Mn 5.10 Mn - 644,574.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 644,574.00
Dec 31, 2025 300,864.00
Sep 30, 2025 677,345.00
Dec 31, 2024 254,783.00